Featured Articles

  1. 5 Lessons Learned Conducting ADHD Clinical Trials 7/31/2014

    At the beginning of a study a lot of time is spent deciding what rating scale will be used, and yet not nearly enough time is spent determining what the precise endpoint will be.

  2. 5 Red Flags Your CRO Is Putting Your Clinical Trial At Risk 7/31/2014

    Some new assignments are always a possibility. Maybe one of the team members left the company or a team member was unavailable because a study that they anticipated would be complete ran over.

  3. Rho Shares Lessons Learned In Rescuing Clinical Trials 4/8/2014

    As a first-class provider of clinical trial rescue services, Triangle-based contract research organization (CRO), Rho, is often called upon to resolve issues when clinical research studies do not go as planned.

  4. Rho Offers Tips For Decreasing Missing Data In Analgesia Clinical Trials 3/3/2014

    Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, offers tips on how to limit the amount of data that goes uncollected during pain trials.

  5. To SPA Or Not To SPA: Understanding Special Protocol Assessments

    The Guidance for Industry: Special Protocol Assessment (SPA) was issued in May of 2002 with the express purpose of allowing FDA to provide input into the design of animal carcinogenicity, product stability, and phase 3 clinical protocols, thereby giving FDA the opportunity to come to agreement with the product sponsor on the scientific and regulatory requirements of the study prior to its initiation.